BIO R&D Expenses

Bio-Rad Laboratories, Inc. Class A Common Stock · R&D Expenses

BIO logo

BIO R&D Expenses

Latest reported$61.20M
BIO Quarterly R&D Expenses ($0.00 → $61.20M)
High-resolution chart · PNG

BIO r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
61,200,000
62,900,000
65,700,000
71,300,000
60,500,000
73,500,000
79,624,000
90,997,000
59,304,000
63,975,000
62,213,000
43,535,000
65,042,000
74,951,000
66,200,000
69,949,000
67,034,000
59,535,000
69,873,000
64,481,000
63,391,000
73,912,000
65,765,000
59,546,000
51,984,000
49,303,000
57,069,000
47,944,000
50,122,000
47,575,000
53,074,000
49,245,000
47,450,000
49,427,000
76,818,000
61,372,000
62,623,000
49,488,000
57,543,000
49,924,000
52,171,000
48,586,000
55,887,000
43,336,000
46,547,000
47,202,000
59,287,000
52,786,000
55,717,000
52,543,000
55,848,000
52,920,000
53,224,000
51,941,000
59,777,000
49,004,000
52,336,000
52,923,000
50,112,000
45,387,000
48,210,000
42,730,000
45,267,000
42,874,000
43,862,000
40,263,000
44,510,000
39,516,000
42,407,000
37,152,000
41,120,000
38,830,000
42,079,000
37,489,000
39,855,000
33,145,000
34,754,000
32,781,000
33,326,000
30,988,000
30,971,000
28,091,000
31,109,000
28,673,000
28,499,000
26,823,000
31,885,000
26,581,000
25,545,000
26,124,000
26,377,000
23,774,000
22,731,000
21,388,000
22,900,000
19,988,000
19,806,000
20,241,000
21,989,000
18,425,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.